Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity
Abstract Osteosarcoma is the most common primary bone tumor, with a poor prognosis owing to the lack of efficient molecular-based targeted therapies. Previous studies have suggested an association between CD151 and distinct consequences in osteosarcoma tumorigenicity. However, the potential of CD151...
Main Authors: | Hongsheng Wang, Xinmeng Jin, Yangfeng Zhang, Zhuoying Wang, Tao Zhang, Jing Xu, Jiakang Shen, Pengfei Zan, Mengxiong Sun, Chongren Wang, Yingqi Hua, Xiaojun Ma, Wei Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Cell & Bioscience |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13578-022-00900-9 |
Similar Items
-
The Context-Dependent Impact of Integrin-Associated CD151 and Other Tetraspanins on Cancer Development and Progression: A Class of Versatile Mediators of Cellular Function and Signaling, Tumorigenesis and Metastasis
by: Sonia Erfani, et al.
Published: (2021-04-01) -
Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature
by: Yujian Zhong, et al.
Published: (2022-10-01) -
Sphingolipid biology /
by: Hirabayashi, Yoshio, et al.
Published: (2006) -
Dysregulation of sphingolipid metabolism in pain
by: Jianfeng Wang, et al.
Published: (2024-03-01) -
CD151 promotes the proliferation and invasion of colorectal cancer cell line HT29
by: LIU Xue-gang, LIU Yan-cai, WU Chun-ping, LI Jing-guang, ZHAO Ling-ling, ZHANG Hao, ZHANG Zhen-ya
Published: (2020-12-01)